Skip to main content
. 2010 Sep 29;10(1A):S74–S82. doi: 10.1102/1470-7330.2010.9027

Figure 2.

Figure 2

Parametric transfer constant (Ktrans) maps overlaid on T1-weighted images in a woman with metastatic neuroendocrine tumour treated using a novel targeted agent (a) before and (b) after one cycle of treatment. A marker lesion at the inferior right tip of the liver (arrow) shows devascularisation with significant reduction in transfer constant after treatment. (Courtesy of Keiko Miyazaki, Institute of Cancer Research, UK.)